• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 277/32 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 277/32

Total number of patents in this class: 147

10-year publication summary

8
13
13
10
7
7
3
4
7
6
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
BASF SE
20933
11
Sumitomo Chemical Company, Limited
9046
8
Syngenta Participations AG
1903
5
Georgia Tech Research Corporation
2733
4
Bayer Cropscience AG
2035
3
Abbvie Inc.
1800
3
The Board of Trustees of the University of Illinois
2688
3
Nissan Chemical Industries, Ltd.
1717
3
Mitsui Chemicals Crop & Life Solutions,Inc.
157
3
AstraZeneca AB
2909
2
Syngenta Crop Protection AG
6054
2
Allergan, Inc.
2349
2
Wisconsin Alumni Research Foundation
3877
2
Takeda Pharmaceutical Company Limited
2713
2
Arkema Inc.
1058
2
Beiersdorf AG
3014
2
East China University of Science and Technology
513
2
FMC Corporation
844
2
Gifu University
133
2
Kissei Pharmaceutical Co., Ltd.
183
2
Other owners 82